|
|
|
Insider
Information: |
Greene Barry E |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
170,289 |
|
Indirect Shares
|
6,153,503 |
|
|
Direct
Value |
$19,194,769 |
|
|
Indirect Value
|
$10,598,303 |
|
|
Total
Shares |
6,323,792 |
|
|
Total
Value |
$29,793,072 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
President |
2020-09-09 |
70,343 |
2020-09-09 |
3,003 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
Premium* |
|
Karyopharm Therapeutics Inc. |
KPTI |
Director |
2022-08-11 |
13,606 |
2015-04-02 |
0 |
Premium* |
|
Acorda Therapeutics Inc |
ACOR |
Director |
2018-05-21 |
1,273 |
2017-01-03 |
0 |
Premium* |
|
Sage Therapeutics, Inc. |
SAGE |
|
2024-08-05 |
85,067 |
2021-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2008-08-13 |
4 |
AS |
$33.92 |
$1,202,726 |
D/D |
(35,440) |
0 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-01-03 |
4 |
AS |
$19.26 |
$58,113 |
D/D |
(3,017) |
0 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-02-09 |
4 |
AS |
$22.65 |
$16,376 |
D/D |
(723) |
0 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-08-01 |
4 |
AS |
$21.57 |
$215,697 |
D/D |
(10,000) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2020-07-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,486 |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2020-07-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
155 |
155 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-02-09 |
4 |
OE |
$22.13 |
$16,000 |
D/D |
723 |
723 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2011-10-11 |
4 |
AB |
$6.73 |
$4,996 |
D/D |
742 |
742 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2018-05-21 |
4 |
D |
$23.10 |
$201,594 |
D/D |
(8,727) |
1,273 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2011-12-12 |
4 |
AB |
$7.15 |
$4,995 |
D/D |
699 |
2,145 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2012-01-09 |
4 |
AB |
$8.80 |
$4,992 |
D/D |
567 |
2,712 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2018-01-17 |
4 |
A |
$0.00 |
$0 |
I/I |
17 |
2,827 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2018-04-16 |
4 |
A |
$0.00 |
$0 |
I/I |
28 |
2,855 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2018-07-10 |
4 |
A |
$0.00 |
$0 |
I/I |
29 |
2,884 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2018-10-18 |
4 |
A |
$0.00 |
$0 |
I/I |
21 |
2,905 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2019-04-09 |
4 |
A |
$0.00 |
$0 |
I/I |
52 |
2,957 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
Director |
|
2015-04-02 |
4 |
B |
$29.31 |
$87,938 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2019-07-11 |
4 |
A |
$0.00 |
$0 |
I/I |
46 |
3,003 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-01-03 |
4 |
OE |
$15.91 |
$48,000 |
D/D |
3,017 |
3,017 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2019-10-23 |
4 |
AS |
$0.00 |
$0 |
I/I |
(5,544) |
3,486 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
COO |
|
2007-10-24 |
4 |
AS |
$31.36 |
$165,126 |
D/D |
(5,220) |
4,551 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2012-02-21 |
4 |
B |
$10.75 |
$19,995 |
D/D |
1,860 |
4,572 |
2.74 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2013-03-08 |
4 |
AS |
$24.43 |
$586,270 |
D/D |
(24,000) |
4,572 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
|
2013-03-14 |
4 |
AS |
$25.00 |
$601,450 |
D/D |
(24,058) |
4,572 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2013-05-28 |
4 |
AS |
$30.00 |
$684,660 |
D/D |
(22,822) |
4,572 |
0 |
- |
|
82 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|